A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles

  • University of Perugia ROR
  • Clinica Valle Giulia ROR

Fertility and Sterility, 76(2), 394-396

DOI 10.1016/s0015-0282(01)01901-x PMID 11476795

Abstract

Objective

To compare the effectiveness of i.m. P and 17alpha-hydroxyprogesterone caproate (17-HPC) for luteal phase support, in patients undergoing IVF-ET cycles.

Design

Prospective, randomized study.

Setting

Patients undergoing IVF-ET in our Centers.

PATIENT(S): The inclusion criteria were the use of GnRH down-regulation and aged <40 years.

INTERVENTION(S): A total of 300 cycles were randomly treated with either 17-HPC (341 mg every 3 days) or P (50 mg daily).

MAIN OUTCOME MEASURE(S): The outcomes of IVF in both study groups were evaluated for biochemical pregnancy, miscarriage, clinical pregnancy, and ongoing pregnancy.

RESULT(S): No difference was found in the main outcome parameters considered.

CONCLUSION(S): Although the results of the study encourage the use of 17-HPC for luteal phase support in patients undergoing IVF-ET program, more studies are necessary to support the hypothesis that it can replace i.m. P-in-oil.

Topics

intramuscular progesterone luteal phase support IVF, 17-alpha-hydroxyprogesterone caproate IVF-ET luteal support, progesterone versus 17-HPC randomized IVF study, luteal phase supplementation in vitro fertilization outcomes, progesterone in oil versus 17-HPC pregnancy rates, prospective randomized study luteal phase support protocols, GnRH down-regulation IVF progesterone supplementation, clinical pregnancy rate luteal support IVF-ET cycles, injectable progesterone comparison assisted reproduction, Unfer V progesterone IVF luteal phase
PMID 11476795 11476795 DOI 10.1016/s0015-0282(01)01901-x 10.1016/s0015-0282(01)01901-x

Cite this article

Costabile, L., Gerli, S., Manna, C., Rossetti, D., Di Renzo, G. C., & Unfer, V. (2001). A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles. *Fertility and sterility*, *76*(2), 394-396. https://doi.org/10.1016/s0015-0282(01)01901-x

Related articles